651 Stock Chart & Stats
€0.01
>-€0.01(-1.25%)
At close: 4:00 PM EST
€0.01
>-€0.01(-1.25%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00K
Market Cap
€2.79M
Enterprise Value€26.92M
Total Cash (Recent Filing)€2.14M
Total Debt (Recent Filing)€21.37M
Price to Earnings (P/E)―
Beta11.34
Next Earnings
Jul 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding1,025,575,800
10 Day Avg. Volume0
30 Day Avg. Volume2,000
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€12.49M
Bulls Say, Bears Say
Bulls Say
Revenue Growth MomentumSustained ~20% TTM revenue growth demonstrates underlying demand for LifeClean’s disinfection products and services. Durable top-line momentum supports potential scale benefits, improved absorption of fixed costs, and gives management runway to focus on margin repair and commercialization over the next several quarters.
Reduction In Total DebtA material reduction in total debt versus prior years improves near-term financing flexibility and reduces immediate refinancing pressure. Lower absolute leverage, even if still high, lessens short-term solvency risk and gives more optionality to prioritize operational fixes or strategic investments.
Niche, Proprietary Product OfferingA focused product set built on proprietary chemistry plus implementation services creates a defensible niche in infection control. This specialized positioning can drive customer stickiness, higher service attach rates, and differentiated outcomes in healthcare/professional channels, supporting durable demand if execution holds.
Bears Say
Negative Gross Profit & Deep LossesPersistent negative gross profit and ~-61% net margin indicate the core unit economics are currently unprofitable. This undermines the company’s ability to scale profitably without substantive changes to pricing, cost structure, or product mix, and makes long-term margin recovery a material operational challenge.
Ongoing Cash BurnConsistent negative operating and free cash flows show the business cannot self-fund operations and requires external financing to run. Continued cash burn increases vulnerability to capital market conditions and constrains investments into sales, R&D, or margin-improvement initiatives over the medium term.
High Leverage & Thin Equity BaseVery high leverage on a thin or negative equity base raises refinancing, covenant, and dilution risk. Limited equity cushion means losses quickly erode solvency metrics, making strategic flexibility costly and increasing the probability of future capital raises that could dilute existing stakeholders.
LifeClean International AB News
651 FAQ
What was LifeClean International AB’s price range in the past 12 months?
LifeClean International AB lowest stock price was <€0.01 and its highest was €0.07 in the past 12 months.
What is LifeClean International AB’s market cap?
LifeClean International AB’s market cap is €2.79M.
When is LifeClean International AB’s upcoming earnings report date?
LifeClean International AB’s upcoming earnings report date is Jul 15, 2026 which is in 5 days.
How were LifeClean International AB’s earnings last quarter?
LifeClean International AB released its earnings results on Apr 29, 2026. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is LifeClean International AB overvalued?
According to Wall Street analysts LifeClean International AB’s price is currently Overvalued.
Does LifeClean International AB pay dividends?
LifeClean International AB does not currently pay dividends.
What is LifeClean International AB’s EPS estimate?
LifeClean International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeClean International AB have?
LifeClean International AB has 1,025,575,800 shares outstanding.
What happened to LifeClean International AB’s price movement after its last earnings report?
LifeClean International AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LifeClean International AB?
Currently, no hedge funds are holding shares in DE:651
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LifeClean International AB
LifeClean International AB (publ) is a Swedish company that engages in the comprehensive process of investigating, manufacturing, promoting, and distributing disinfection agents within Sweden. A key innovation from the company is its patented surface disinfectant. This powerful formula is engineered to eradicate a wide array of harmful microorganisms, including spores, fungi, tenacious biofilms, bacteria, and viruses. It is designed for versatile application across various equipment and surfaces, encompassing flooring, walls, furniture, and overhead structures. The enterprise was founded in 2012 and maintains its operational base in Uddevalla, Sweden.